7 active warrant series covering 14,521,146 shares (~16.1% potential dilution); nearest expiry 2027-04-11.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| warrant | $1.20 | Apr 11, 2027 193d | 3.6M | ITM | 4.0% | C$4.3M | Auto |
| finder | $0.90 | May 16, 2027 228d | 274K | ITM | 0.3% | C$247K | Auto |
| warrant | $0.90 | May 16, 2027 228d | 4.4M | ITM | 4.8% | C$3.9M | Auto |
| finder | $0.90 | May 26, 2027 238d | 8K | ITM | 0.0% | C$7K | Auto |
| warrant | $0.90 | May 26, 2027 238d | 3.1M | ITM | 3.4% | C$2.8M | Auto |
| warrant | $1.13 | Dec 4, 2027 430d | 1.6M | ITM | 1.8% | C$1.8M | Auto |
| finder | $1.08 | Dec 4, 2027 430d | 1.6M | ITM | 1.8% | C$1.8M | Auto |
Basis: Current shares & price vs as-filed warrant terms.
8 option grants covering 8,698,356 shares (~9.7% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $8.75 | Oct 21, 2026 21d | 203K | OTM | 0.2% | C$1.8M | Auto |
| option | $2.65 | Jan 11, 2028 468d | 171K | OTM | 0.2% | C$452K | Auto |
| option | $2.40 | Jul 5, 2028 644d | 298K | OTM | 0.3% | C$715K | Auto |
| option | $0.90 | May 16, 2029 959d | 734K | ITM | 0.8% | C$661K | Auto |
| option | $0.60 | May 28, 2030 1336d | 1.8M | ITM | 2.0% | C$1.1M | Auto |
| option | $1.81 | Jan 14, 2031 1567d | 4.8M | OTM | 5.3% | C$8.6M | Auto |
| option | $1.38 | Mar 10, 2031 1622d | 600K | OTM | 0.7% | C$828K | Auto |
| option | $1.14 | May 25, 2031 1698d | 90K | ITM | 0.1% | C$103K | Auto |
90,122,411 shares outstanding, plus 14,521,146 from warrants and 8,698,356 from options — a fully diluted 113,341,913 shares, or ~25.8% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
7 active warrant series covering 14,521,146 shares (~16.1% potential dilution); nearest expiry 2027-04-11.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| warrant | $1.20 | Apr 11, 2027 193d | 3.6M | ITM | 4.0% | C$4.3M | Auto |
| finder | $0.90 | May 16, 2027 228d | 274K | ITM | 0.3% | C$247K | Auto |
| warrant | $0.90 | May 16, 2027 228d | 4.4M | ITM | 4.8% | C$3.9M | Auto |
| finder | $0.90 | May 26, 2027 238d | 8K | ITM | 0.0% | C$7K | Auto |
| warrant | $0.90 | May 26, 2027 238d | 3.1M | ITM | 3.4% | C$2.8M | Auto |
| warrant | $1.13 | Dec 4, 2027 430d | 1.6M | ITM | 1.8% | C$1.8M | Auto |
| finder | $1.08 | Dec 4, 2027 430d | 1.6M | ITM | 1.8% | C$1.8M | Auto |
Basis: Current shares & price vs as-filed warrant terms.
8 option grants covering 8,698,356 shares (~9.7% potential dilution). Counted apart from the warrants above.
| Type | Status | Source | |||||
|---|---|---|---|---|---|---|---|
| option | $8.75 | Oct 21, 2026 21d | 203K | OTM | 0.2% | C$1.8M | Auto |
| option | $2.65 | Jan 11, 2028 468d | 171K | OTM | 0.2% | C$452K | Auto |
| option | $2.40 | Jul 5, 2028 644d | 298K | OTM | 0.3% | C$715K | Auto |
| option | $0.90 | May 16, 2029 959d | 734K | ITM | 0.8% | C$661K | Auto |
| option | $0.60 | May 28, 2030 1336d | 1.8M | ITM | 2.0% | C$1.1M | Auto |
| option | $1.81 | Jan 14, 2031 1567d | 4.8M | OTM | 5.3% | C$8.6M | Auto |
| option | $1.38 | Mar 10, 2031 1622d | 600K | OTM | 0.7% | C$828K | Auto |
| option | $1.14 | May 25, 2031 1698d | 90K | ITM | 0.1% | C$103K | Auto |
90,122,411 shares outstanding, plus 14,521,146 from warrants and 8,698,356 from options — a fully diluted 113,341,913 shares, or ~25.8% above today's count if every one of them is exercised.
Price history with the company's supply walls overlaid — warrants (amber), employee and consultant options (pink), and free-trading unlock dates (violet). Each wall sits at the price the paper is struck at today, restated through any consolidation, and is measured in the SHARES it can issue rather than the number of certificates. Levels and dates are Pacific Time.
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
An issuer that discloses only a plan total appears as one line at its weighted-average exercise price and weighted-average remaining life — the filing's own summary, not a per-grant schedule.
